Reducing the GI Risks of Antiplatelet Therapy and NSAID Use
Published: October 03, 2008

- There is uncertainty about how to best prevent bleeding complications in patients receiving antiplatelet therapy and NSAIDs.
- Patients are on these agents for longer periods than in the past, increasing their time of risk.
- Evaluation of the risk profile for each patient is critical.